What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to officially announce Merck & Co., Inc.'s financial results for the third quarter of 2016. It serves as a notification to investors and the public by incorporating by reference the company's earnings press release and supplemental financial information.

Where can I find the detailed financial information for the third quarter of 2016?

The detailed financial information for the third quarter of 2016 is primarily contained in the press release (Exhibit 99.1) and certain supplemental information (Exhibit 99.2) that are incorporated by reference into this 8-K filing. Investors would need to refer to these exhibits for specifics on revenue, earnings, and other financial metrics.

Does this 8-K filing contain the full financial statements for the quarter?

No, this 8-K filing itself does not contain the full financial statements. It serves as a notification of the earnings release and directs investors to the attached exhibits (press release and supplemental information) for the detailed financial results and commentary.

What is the significance of 'Information shall not be deemed to be 'filed' for purposes of Section 18'?

This disclaimer means that the financial information provided under Item 2.02 and its incorporated exhibits is not subject to the same liability provisions as other 'filed' documents under Section 18 of the Securities Exchange Act of 1934. While it's public information, it's treated differently in terms of legal accountability for its content compared to information officially 'filed' within the 8-K itself.

MRK 8-K: Earnings & Results

Summary

Merck & Co., Inc. (MRK) filed an 8-K report on October 25, 2016, to announce its third-quarter 2016 financial results. The report, which incorporates by reference a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2), provides key operational and financial performance details for the quarter ended October 24, 2016. Investors should note that this filing serves as a notification of the earnings release and is not intended to be a detailed financial statement itself. The primary source of detailed information regarding the third-quarter performance is the press release and supplemental data attached as exhibits. These documents would contain information on revenue, earnings per share, product performance, and any forward-looking guidance or strategic updates from Merck's management.

Key Highlights

1Filing announces Merck's third-quarter 2016 financial results.
2The report incorporates by reference a press release detailing the earnings.
3Supplemental financial information not included in the press release is also incorporated.
4The event date associated with the filing is October 24, 2016.
5This 8-K is a notification of earnings and references external documents for detailed financial data.
6The filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
7Information furnished under Item 2.02 is not deemed 'filed' for Section 18 purposes.

Merck & Co., Inc. 8-K Report, Financial Results (Oct 25, 2016)

Summary

Key Highlights

Frequently Asked Questions